scientist at nova southeastern university, United States
Dr. Anusha Thumma holds a Ph.D. in Pharmaceutical Sciences and specializes in drug formulation, abuse-deterrent technologies, inhalation products, and vaccine adjuvants. With expertise in HPLC, qPCR, ELISA, DSC, and flow cytometry, she ensures regulatory compliance with FDA, ICH, GMP, and GLP standards. She has worked as an Associate Scientist at Lupin Pharmaceuticals, an R&D Scientist at US Pharma LTD, and an Associate Professor at Radex Regulatory Affairs. Her research includes mRNA vaccine lipid nanoparticles and opioid abuse-deterrent formulations. She excels in project management, data analysis (Minitab), and cross-functional collaboration.
Dr. Anusha Thumma holds a Doctor of Philosophy (PhD) in Pharmaceutical Sciences from Nova Southeastern University, USA (2023), where her dissertation focused on Abuse-Deterrent Composites: A Multi-Angle Approach. She earned her Master of Pharmacy (MPharm) from Osmania University, India (2013), specializing in Formulation and Characterization of Imiquimod Multiple Emulsion as a Novel Vaccine Delivery System. Her academic journey began with a Bachelor of Pharmacy (BPharm) from Kakatiya University, India (2011). With a strong foundation in pharmaceutical sciences, her research contributions span drug formulation, regulatory affairs, and vaccine development. ππ¬
π Academic Excellence & Professional Achievements
Dr. Anusha Thumma has been recognized with multiple prestigious scholarships and grants for her outstanding academic and research contributions. She received a fully funded PhD scholarship and a PhD Scholar Stipend from Nova Southeastern University, USA, along with the President’s Faculty Research and Development Grant and HPD Research Grant for her research excellence. She also secured fully funded scholarships for her Masterβs (Osmania University) and Bachelorβs (Kakatiya University) degrees in India. Additionally, she holds a Professional Diploma in Regulatory Affairs (USA), is a Registered Pharmacist (India), and has attended webinars on drug discovery. πππ
π¬ Research Focus Areas
Dr. Anusha Thummaβs research primarily focuses on environmental remediation π±, pharmaceutical sciences π, and drug abuse potential π§ͺ. She has made significant contributions to water purification by exploring biochar-based adsorption for removing heavy metals (cadmium, zinc, arsenic) and dyes from polluted water. Her expertise extends to pharmaceutical formulations, particularly in abuse-deterrent drug delivery systems. Additionally, she investigates the toxicity and abuse potential of fentanyl analogues. Her interdisciplinary work integrates biopolymer-based cryostructures, advancing biomedical and pharmaceutical applications. Through her research, she aims to enhance sustainable environmental solutions and safer pharmaceutical formulations. ππ¬π§
Publication Top Notes
Adsorptive removal of arsenic from drinking water using KOH-modified sewage sludge-derived biochar
Exploring the efficiency of sodium alginate beads and Cedrus deodara sawdust for adsorptive removal of crystal violet dye
Advances in cryostructures and their applications in biomedical and pharmaceutical products
Abuse potential of fentanyl and fentanyl analogues
Removal of cadmium and zinc from water using sewage sludge-derived biochar
Potential of easily available low-cost raw cotton for the elimination of methylene blue dye from polluted water
Mr. Anand Kumar, Babasaheb Bhimrao Ambedkar University Lucknow, India
π Dr. Anand Kumar is a dedicated researcher and educator with a profound academic background. He holds a Ph.D. in Pharmaceutical Sciences, specializing in areas like Cancer Biology, Muscle Biology, and Sarcopenia. An alumnus of prestigious institutions such as Babasaheb Bhimrao Ambedkar University and Chhatrapti Shahu Ji Maharaj University, Dr. AnandKumar has been honored with fellowships from Indian Council of Medical Research and University Grants Commission. His commitment to advancing pharmaceutical knowledge is underscored by his multiple qualifications and extensive research experience. With a passion for understanding and combating diseases, he represents a beacon of excellence in the field. π
π Dr. AnandKumar’s educational journey is marked by a series of impressive accomplishments and a steadfast pursuit of excellence in pharmaceutical sciences. His academic odyssey began with an Intermediate degree in Physics, Chemistry, and Maths from the UP Board, where he attained a commendable first-class score. Venturing further into the realm of pharmacy, he obtained a D. Pharm from Sarojini Naidu Medical College, Agra, demonstrating his early dedication to the field. Undeterred by challenges, he pursued a B. Pharm from Chhatrapti Shahu Ji Maharaj University, Kanpur, and later, an M. Pharm in Pharmacology from Babasaheb Bhimrao Ambedkar University, Lucknow, where he consistently achieved first-class distinctions.His academic journey culminated in a significant milestone with a Ph.D. in Pharmaceutical Sciences from the same institution, where his thesis was submitted in July 2023. Dr. AnandKumar’s relentless pursuit of knowledge and his commitment to academic excellence are evident in his consistent academic achievements. Through his rigorous academic training, he has honed his expertise in areas such as pharmacology and pharmaceutical sciences, paving the way for impactful contributions to the field. Dr. AnandKumar’s educational trajectory exemplifies resilience, dedication, and a profound passion for advancing pharmaceutical research and practice. π
Honors, Recognition, and Awards:
π Dr. AnandKumar’s contributions to pharmaceutical research have been recognized through prestigious honors and awards. In 2022, he was bestowed with the Indian Council of Medical Research (ICMR) Senior Research Fellowship (SRF) by the Ministry of Health and Family Welfare, Government of India, acknowledging his exceptional research prowess. Prior to this, he received the PGSPROF Fellowship from the University Grants Commission (UGC) between 2016 and 2018, further affirming his dedication to academic excellence. Additionally, Dr. AnandKumar’s exemplary performance is underscored by his remarkable achievement of qualifying the Graduate Pharmacy Aptitude Test (GPAT) five times between 2017 and 2023, highlighting his commitment to continuous learning and proficiency in pharmaceutical sciences. π
Professional Experience:
π¨βπ« Dr. AnandKumar’s professional journey includes both teaching and research experiences, shaping him into a well-rounded pharmaceutical scientist. His teaching tenure spans six months, during which he imparted knowledge and mentored students in various aspects of pharmacy. Complementing his role in academia, Dr. AnandKumar has amassed valuable research experience in diverse domains. Through his engagement in research, he has delved into intricate subjects such as Cancer Biology, Muscle Biology, and Sarcopenia, contributing significantly to the advancement of pharmaceutical sciences. His dual expertise in teaching and research reflects his commitment to academic excellence and his passion for pushing the boundaries of scientific inquiry. ππ¬
Research Focus:
π¬ Dr. Anand Kumar’s research focus encompasses a broad spectrum of pharmaceutical sciences, with a particular emphasis on combating various aspects of muscle biology-related disorders. His work delves into elucidating mechanisms underlying skeletal muscle wasting conditions such as sarcopenia, diabetic muscle atrophy, and muscle damage induced by diverse factors. Through innovative approaches including pharmacological interventions and targeted drug delivery systems, he aims to mitigate muscle wasting and associated inflammatory responses. Dr. AnandKumar’s multidisciplinary research endeavors, as evidenced by his publications, contribute significantly to understanding and addressing the complexities of muscle-related pathologies, paving the way for novel therapeutic strategies in the field. π